Selective Sensitization of Peripheral Blood T Lymphocytes to Hepatitis B Core Antigen in Patients with Chronic Active Hepatitis Type B

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1986 Dec 1

PMID 3494552

Citations 15

Authors

C Ferrari

A Penna

P Sansoni

T Giuberti

T M Neri

F V Chisari

F Fiaccadori

Affiliations

Soon will be listed here.

Abstract

The proliferative response of peripheral blood T cells to hepatitis B surface antigen (HBsAg), pre-S antigen and hepatitis B core antigen (HBcAg) has been studied in 20 patients with hepatitis B virus induced chronic active hepatitis (CAH) and in 12 control subjects. Eleven of the 20 CAH patients showed a significant T lymphocyte proliferative response to HBcAg, whereas no proliferation was detectable in response to envelope antigens (HBs and pre-S) in any patient. T cell subset fractionation revealed that HBcAg specific proliferation was limited to the CD4+ (helper/inducer) population. CD8+ (suppressor/cytotoxic) T cells were unresponsive to HBcAg and did not suppress the proliferative response of autologous CD4+ cells. The HBcAg specific T cell proliferative response did not correlate with serum anti-core antibody titres or with biochemical evidence of liver disease. The present results show the selective presence of HBcAg-sensitized T cells in the peripheral blood of patients with HBsAg positive CAH and suggest that the peripheral lymphoid compartment may not reflect immunopathogenetically important cellular events operative at the site of tissue injury.

Citing Articles

Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.

Tachtatzis P, Marshall A, Arvinthan A, Aravinthan A, Verma S, Penrhyn-Lowe S PLoS One. 2015; 10(5):e0127511.

PMID: 26024529 PMC: 4449162. DOI: 10.1371/journal.pone.0127511.

An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection.

Huang L, Wu H, Chen P, Chen D Proc Natl Acad Sci U S A. 2006; 103(47):17862-7.

PMID: 17095599 PMC: 1635544. DOI: 10.1073/pnas.0608578103.

Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells.

Chichester J, Feitelson M, Calkins C Immunology. 2006; 118(4):438-48.

PMID: 16762029 PMC: 1782315. DOI: 10.1111/j.1365-2567.2006.02397.x.

Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.

Menne S, Roneker C, Roggendorf M, Gerin J, Cote P, Tennant B J Virol. 2002; 76(4):1769-80.

PMID: 11799172 PMC: 135887. DOI: 10.1128/jvi.76.4.1769-1780.2002.

Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.

Menne S, Maschke J, Tolle T, Lu M, Roggendorf M J Virol. 1997; 71(1):65-74.

PMID: 8985324 PMC: 191025. DOI: 10.1128/JVI.71.1.65-74.1997.

References

Lee W, REED W, Osman C, VAHRMAN J, Zuckerman A, Eddleston A . Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut. 1977; 18(3):250-7. PMC: 1411397. DOI: 10.1136/gut.18.3.250. View

Aldershvile J, Dietrichson O, Hardt F, Nielsen J, Skinhoj P . Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease. Scand J Gastroenterol. 1977; 12(8):917-22. DOI: 10.3109/00365527709181350. View

Wysocki L, Sato V . "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978; 75(6):2844-8. PMC: 392661. DOI: 10.1073/pnas.75.6.2844. View

Beutner K, Tiku M, Ogra P . Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers. Infect Immun. 1978; 21(2):480-8. PMC: 422021. DOI: 10.1128/iai.21.2.480-488.1978. View

Tiku M, Beutner K, Tiku K, Ogra P . Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans. J Infect Dis. 1978; 138(5):587-96. DOI: 10.1093/infdis/138.5.587. View

Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P . Hepatitis B virus genes and their expression in E. coli. Nature. 1979; 282(5739):575-9. DOI: 10.1038/282575a0. View

Trevisan A, Realdi G, Alberti A, Ongaro G, Pornaro E, Meliconi R . Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology. 1982; 82(2):218-22. View

Thomas H, Brown D, Routhier G, Janossy G, Kung P, Goldstein G . Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology. 1982; 2(2):202-4. DOI: 10.1002/hep.1840020203. View

Mondelli M, Vergani G, Alberti A, Vergani D, Portmann B, Eddleston A . Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 1982; 129(6):2773-8. View

10.

Stibbe W, Gerlich W . Variable protein composition of hepatitis B surface antigen from different donors. Virology. 1982; 123(2):436-42. DOI: 10.1016/0042-6822(82)90275-6. View

11.

Stibbe W, Gerlich W . Structural relationships between minor and major proteins of hepatitis B surface antigen. J Virol. 1983; 46(2):626-8. PMC: 255166. DOI: 10.1128/JVI.46.2.626-628.1983. View

12.

Alexander G, Nouri-Aria K, Eddleston A, Williams R . Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet. 1983; 1(8337):1291-3. DOI: 10.1016/s0140-6736(83)92410-8. View

13.

Machida A, Kishimoto S, Ohnuma H, Miyamoto H, Baba K, Oda K . A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology. 1983; 85(2):268-74. View

14.

. Suppressor cell function in chronic liver disease. Lancet. 1983; 2(8345):342-3. View

15.

Fattovich G, Alberti A, Crivellaro C, Pontisso P, Noventa F, Realdi G . Cellular immunity to the hepatitis B virion in acute hepatitis type B. Clin Exp Immunol. 1983; 53(3):645-50. PMC: 1535662. View

16.

Damle N, Mohagheghpour N, Engleman E . Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells. J Immunol. 1984; 132(2):644-50. View

17.

Naumov N, Mondelli M, Alexander G, Tedder R, Eddleston A, Williams R . Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology. 1984; 4(1):63-8. DOI: 10.1002/hep.1840040111. View

18.

Celis E, Kung P, Chang T . Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis. J Immunol. 1984; 132(3):1511-6. View

19.

Neurath A, Kent S, Strick N . Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Science. 1984; 224(4647):392-5. DOI: 10.1126/science.6200931. View

20.

Mondelli M, Eddleston A . Mechanisms of liver cell injury in acute and chronic hepatitis B. Semin Liver Dis. 1984; 4(1):47-58. DOI: 10.1055/s-2008-1040645. View